ProMIS Neurosciences Inc. financial data

Symbol
PMN on Nasdaq
Location
Suite 200, 1920 Yonge Street, Toronto, Ontario, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 355 % +144%
Debt-to-equity 103 % -69.7%
Return On Equity -103 % +82.5%
Return On Assets -50.6 % +62.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.8M shares +73.4%
Common Stock, Shares, Outstanding 32.7M shares +72.4%
Entity Public Float 29.7M USD
Weighted Average Number of Shares Outstanding, Basic 34.9M shares +76.3%
Weighted Average Number of Shares Outstanding, Diluted 34.9M shares +76.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 21.1M USD +197%
General and Administrative Expense 6.98M USD +23.2%
Operating Income (Loss) -28.1M USD -120%
Nonoperating Income (Expense) 19.7M USD +3273%
Net Income (Loss) Attributable to Parent -8.43M USD +30.9%
Earnings Per Share, Basic 0 USD/shares +87%
Earnings Per Share, Diluted 0 USD/shares +87%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.51M USD +354%
Assets, Current 9.51M USD +575%
Intangible Assets, Net (Excluding Goodwill) 18K USD -17.1%
Assets 9.51M USD +575%
Accounts Payable, Current 2.78M USD +38%
Accrued Liabilities, Current 7.04M USD +509%
Liabilities, Current 9.82M USD +210%
Liabilities 9.89M USD +168%
Accumulated Other Comprehensive Income (Loss), Net of Tax -371K USD 0%
Retained Earnings (Accumulated Deficit) -108M USD -8.45%
Stockholders' Equity Attributable to Parent -383K USD +83.2%
Liabilities and Equity 9.51M USD +575%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.93M USD +52.1%
Net Cash Provided by (Used in) Financing Activities 190K USD
Common Stock, Shares, Issued 32.7M shares +72.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.93M USD +51.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.51M USD +354%
Deferred Tax Assets, Valuation Allowance 31.9M USD +15%
Deferred Tax Assets, Gross 31.9M USD +15%
Depreciation 4.69K USD -81.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.78M USD +93%
Deferred Tax Assets, Operating Loss Carryforwards 24.9M USD +17.5%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 70M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 108M USD +10.6%
Preferred Stock, Shares Outstanding 0 shares -100%
Amortization of Intangible Assets 4.99K USD -6.38%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 1.2M USD +1290%
Interest Expense 76.8K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares